{"id":"https://openalex.org/W2925255701","doi":"https://doi.org/10.1182/blood-2018-99-118807","title":"Therapeutic Disassembly of Leukemogenic Enhancer Complexes","display_name":"Therapeutic Disassembly of Leukemogenic Enhancer Complexes","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2925255701","doi":"https://doi.org/10.1182/blood-2018-99-118807","mag":"2925255701"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-118807","doi":"https://doi.org/10.1182/blood-2018-99-118807","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118807","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029868043","display_name":"Lauren Forbes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Forbes","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055813888","display_name":"Krasnopolsky Isaac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Krasnopolsky Isaac","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091449830","display_name":"Gerard Minuesa","orcid":"https://orcid.org/0000-0001-9911-8428","observed_orcids":["https://orcid.org/0000-0001-9911-8428"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gerard Minuesa Dinares","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075756601","display_name":"Michael G. Kharas","orcid":"https://orcid.org/0000-0002-1165-6991","observed_orcids":["https://orcid.org/0000-0002-1165-6991"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael G. Kharas","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055053315","display_name":"Alex Kentsis","orcid":"https://orcid.org/0000-0002-8063-9191","observed_orcids":["https://orcid.org/0000-0002-8063-9191"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Kentsis","raw_affiliation_strings":["Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055813888","https://openalex.org/A5091449830"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"1352","last_page":"1352"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.026499999687075615,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/c-myb","display_name":"MYB","score":0.8740000128746033},{"id":"https://openalex.org/keywords/creb-binding-protein","display_name":"CREB-binding protein","score":0.8730000257492065},{"id":"https://openalex.org/keywords/p300","display_name":"P300","score":0.9139999747276306},{"id":"https://openalex.org/keywords/kix-domain","display_name":"KIX domain","score":0.8870000243186951},{"id":"https://openalex.org/keywords/peptidomimetic-inhibitors","display_name":"peptidomimetic inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/protein-protein-interaction-disruption","display_name":"protein-protein interaction disruption","score":0.7390000224113464},{"id":"https://openalex.org/keywords/peptide-protein-conjugation","display_name":"peptide-protein conjugation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hematopoietic-progenitor-cells","display_name":"hematopoietic progenitor cells","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5700464248657227},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5649720430374146},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5230123400688171},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.48540911078453064},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.48045939207077026},{"id":"https://openalex.org/C111936080","wikidata":"https://www.wikidata.org/wiki/Q913367","display_name":"Enhancer","level":4,"score":0.47517791390419006},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4521862864494324},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.4476355016231537},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.42678090929985046},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.36293458938598633},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2517569363117218},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.24447187781333923},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.24336066842079163},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22278186678886414},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1982974112033844},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.08742266893386841},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-118807","doi":"https://doi.org/10.1182/blood-2018-99-118807","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118807","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2740458304","https://openalex.org/W3126274896","https://openalex.org/W4400740232","https://openalex.org/W4405040365","https://openalex.org/W2087520814","https://openalex.org/W4310108124","https://openalex.org/W127195683","https://openalex.org/W2410715944","https://openalex.org/W2591741817","https://openalex.org/W7149019903"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"a":[2,37,59,162],"detailed":[3],"understanding":[4],"of":[5,9,20,33,58,61,84,94,112,148,170,217,224,235],"the":[6,31,54,81,91,135,146],"genetic":[7],"mechanisms":[8,137,223],"acute":[10,62],"myeloid":[11],"leukemia":[12,114,153],"(AML),":[13],"treatments":[14],"remain":[15],"deeply":[16],"inadequate.":[17],"Aberrant":[18],"activity":[19],"hematopoietic":[21,120],"transcription":[22,42],"factors":[23],"and":[24,45,56,96,107,130,191,221],"their":[25,197],"co-activators":[26],"has":[27],"been":[28],"implicated":[29],"in":[30,152,167,193,229],"expression":[32,151,227],"leukemogenic":[34,149,218],"genes,":[35],"providing":[36],"compelling":[38],"therapeutic":[39,201,212,215],"target.":[40],"Hematopoietic":[41],"factor":[43],"MYB":[44,95],"its":[46],"co-activator":[47],"CREB-binding":[48],"protein/P300":[49],"(CBP/P300)":[50],"are":[51,184],"required":[52],"for":[53,166,203,214],"initiation":[55],"maintenance":[57],"variety":[60],"leukemias.":[63],"Using":[64],"protein":[65],"engineering":[66],"methods,":[67],"we":[68,159],"have":[69,160],"developed":[70,161],"cell-penetrant":[71],"peptidomimetic":[72],"inhibitors":[73],"that":[74,181],"interfere":[75],"with":[76,103],"this":[77,207],"interaction":[78,93,132],"by":[79,138,172,188],"targeting":[80],"KIX":[82,102],"domain":[83],"CBP/P300.":[85],"A":[86],"second-generation":[87],"inhibitor":[88],"based":[89],"on":[90],"chimeric":[92],"CREB,":[97],"termed":[98],"CRYBMIM,":[99],"binds":[100],"CPB/P300":[101],"10-fold":[104],"higher":[105],"affinity":[106],"exhibits":[108],"logarithmic":[109],"cell":[110],"killing":[111],"most":[113],"subtypes,":[115],"while":[116],"sparing":[117],"healthy":[118],"human":[119],"progenitor":[121],"cells":[122,190],"(Figure":[123],"1).":[124],"Comparative":[125],"gene":[126,150,226],"expression,":[127],"chromatin":[128],"mapping,":[129],"protein-protein":[131],"mapping":[133],"elucidate":[134],"molecular":[136],"which":[139],"CRYBMIM":[140],"dismantles":[141],"oncogenic":[142],"enhanceosomes,":[143],"leading":[144],"to":[145,176,237],"downregulation":[147],"but":[154],"not":[155],"normal":[156],"cells.":[157],"Finally,":[158],"peptide-protein":[163],"conjugation":[164,175],"strategy":[165,213],"vivo":[168],"delivery":[169],"peptidomimetics":[171],"polyvalent":[173],"reversible":[174],"transferrin":[177],"(TF).":[178],"We":[179],"found":[180],"TF-peptide":[182],"conjugates":[183],"readily":[185],"taken":[186],"up":[187],"AML":[189,194],"accumulate":[192],"nuclei,":[195],"supporting":[196],"translation":[198],"into":[199],"new":[200],"strategies":[202],"patients.":[204],"Taken":[205],"together,":[206],"work":[208],"advances":[209],"an":[210],"effective":[211],"disruption":[216],"enhancer":[219],"complexes,":[220],"defines":[222],"aberrant":[225],"control":[228],"AML.":[230],"Disclosures":[231],"No":[232],"relevant":[233],"conflicts":[234],"interest":[236],"declare.":[238]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2019-04-01T00:00:00"}